Srinivas Devarakonda
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 38
- Multiple Myeloma Research and Treatments 31
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 4
-
- Protein Degradation and Inhibitors 9
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
- Co-authors
- Yvonne A. Efebera (19 shared papers)Nidhi Sharma (22 shared papers)Glenn Mills (10 shared papers)Abdullah Khan (28 shared papers)Runhua Shi (6 shared papers)Naresh Bumma (26 shared papers)Don M. Benson (17 shared papers)Lihong Liu (1 shared paper)
- Journals
- Blood (14 papers)Biology of Blood and Marrow Transplantation (6 papers)Journal of Clinical Oncology (3 papers)Journal of Clinical Medicine (2 papers)Cancers (2 papers)
- Partner nations
- United StatesGermanyPuerto Rico
In The Last Decade
Srinivas Devarakonda
44 papers receiving 230 citations
Peers
Comparison fields: 5 of 59
- Hematology 103
- Oncology 94
- Internal Medicine 12
- Genetics 17
- Immunology 29
Countries citing papers authored by Srinivas Devarakonda
This map shows the geographic impact of Srinivas Devarakonda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Devarakonda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Devarakonda more than expected).
Fields of papers citing papers by Srinivas Devarakonda
This network shows the impact of papers produced by Srinivas Devarakonda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Devarakonda. The network helps show where Srinivas Devarakonda may publish in the future.
Co-authors
The 25 scholars most cited alongside Srinivas Devarakonda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 33 | |
| 2 | 2021 | 25 | |
| 3 | 2009 | 22 | |
| 4 | 2019 | 16 | |
| 5 | 2021 | 11 | |
| 6 | Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality. | 2016 | 11 |
| 7 | 2022 | 10 | |
| 8 | 2009 | 8 | |
| 9 | 2024 | 8 | |
| 10 | 2019 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2015 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2008 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2018 | 3 |
About Srinivas Devarakonda
Srinivas Devarakonda is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 234 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Peptidase Inhibition and Analysis (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (103 citations), Oncology (94 citations), Internal Medicine (12 citations), Genetics (17 citations) and Immunology (29 citations). Srinivas Devarakonda has collaborated with scholars based in United States, Germany and Puerto Rico. Frequent co-authors include Yvonne A. Efebera, Nidhi Sharma, Glenn Mills, Abdullah Khan, Runhua Shi, Naresh Bumma, Don M. Benson, Lihong Liu, Maria Chaudhry and Hannah Taylor. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Journal of Clinical Medicine and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.